Medical Devices Kenya

Kenya Heart Failure Devices Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Kenya Heart Failure Devices Market Industry Trends and Forecast to 2034: Segmented by (Device, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Kenya · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $7.3 Mn Placeholder estimate
Estimate 2025 $8.0 Mn 0.1% of the global market
Projected 2034 $18.2 Mn 126.3% Adds $10.1 Mn over 9 forecast years
CAGR 2025–2034 9.5% Faster than 48% of 173 Medical Devices markets here
Key players 5
  • Kenya is 0.06% of the global market.
  • In Africa, the largest is South Africa at $75.8 Mn.
  • Fastest growing: Kenya (this report) at 9.5% a year.
  • Kenya ranks 3rd of 3 by size in Africa.

Market size projection

Kenya

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$10.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Heart Failure Devices Market market size by year, Kenya
YearMarket sizeChange that yearSince 2025
2024 (estimate) $7.3 Mn — —
2025 (base) $8.0 Mn +$0.7 Mn —
2026 (forecast) $8.8 Mn +$0.8 Mn +9.5%
2027 (forecast) $9.6 Mn +$0.8 Mn +19.9%
2028 (forecast) $10.5 Mn +$0.9 Mn +31.3%
2029 (forecast) $11.5 Mn +$1.0 Mn +43.8%
2030 (forecast) $12.6 Mn +$1.1 Mn +57.4%
2031 (forecast) $13.8 Mn +$1.2 Mn +72.4%
2032 (forecast) $15.2 Mn +$1.3 Mn +88.8%
2033 (forecast) $16.6 Mn +$1.4 Mn +106.7%
2034 (forecast) $18.2 Mn +$1.6 Mn +126.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Kenya Heart Failure Devices Market Analysis at a glance
Market size, 2025$8.0 Mn placeholder estimate
Forecast, 2034$18.2 Mn placeholder estimate
Growth (CAGR), 2025–20349.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDevice, use and end user (see all)
Key playersAbbott Laboratories, Medtronic, Boston Scientific Corporation, Abiomed (Johnson & Johnson), Impulse Dynamics (see all)
Regulator in KenyaPPBSource: Pharmacy and Poisons Board. Checked 14 Nov 2026.
Active clinical trials1 in KenyaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Kenya. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Kenya Heart Failure Devices Market Analysis Executive Summary

Heart failure devices help weak hearts pump or keep rhythm, including pumps, defibrillators, resynchronisation devices and sensors.

Key segments of the heart Failure Devices market include device (Ventricular Assist Devices, CRT Devices and ICDs) and use (Bridge to Transplant, Destination Therapy and Monitoring).

Bar chart: Kenya Heart Failure Devices market size, 2024–2034, placeholder estimates. $7.3 Mn in 2024, $8.0 Mn in 2025 and $18.2 Mn in 2034, 9.5% CAGR.
Kenya Heart Failure Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Kenya Heart Failure Devices Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the heart Failure Devices market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the heart Failure Devices market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the heart Failure Devices market.

Competitive Landscape for Heart Failure Devices Market in Kenya

The heart Failure Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Heart Failure Devices Market in Kenya

Heart Failure Devices in Kenya: rules, payment and research

The Pharmacy and Poisons Board (PPB) registers medical devices as well as medicines.⁠[1] The Social Health Authority (SHA) replaced the National Health Insurance Fund (NHIF) in October 2024.⁠[2] ClinicalTrials.gov lists 1 study on Heart Failure Devices that is recruiting, active or about to start in Kenya.⁠[3] Early deaths from long-term diseases: 17.1% in 2023, the latest WHO figure for Kenya.⁠[4]

[1] Pharmacy and Poisons Board. Checked 14 Nov 2026.

[2] Social Health Authority. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Kenya. Retrieved 12 Nov 2026.

[4] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how heart Failure Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Kenya.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Heart Failure Devices right now, from free public sources.

Clinical trials

1 active trial in Kenya

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Biotronik SE & Co. KG 4 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Corvia Medical 2 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Supira Medical 2 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Impulse Dynamics 2 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Shenzhen Core Medical Technology CO.,LTD. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Heart Failure Devices in context

Kenya compared

  • Early deaths from long-term diseases: 17.1% (2023). World: 17.2% (2023). 16th highest of the 17 countries we cover in Africa.[1]
  • Health spending per person: 85 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 17 countries we cover in Africa.[2]
  • Doctors: 0.29 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 6th highest of the 17 countries we cover in Africa.[3]

[1] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Heart Failure Devices market in Kenya?
Placeholder estimate: about $8.0 Mn in 2025, rising to about $18.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Heart Failure Devices market in Kenya growing?
Placeholder estimate: about 9.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Heart Failure Devices market report cover?
The report splits the market by device (Ventricular Assist Devices, CRT Devices, ICDs, Implantable Monitors), use (Bridge to Transplant, Destination Therapy, Monitoring) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Heart Failure Devices market?
Key players include Abbott Laboratories, Medtronic, Boston Scientific Corporation, Abiomed (Johnson & Johnson) and Impulse Dynamics.
What is driving the Heart Failure Devices market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the heart Failure Devices market.
Who regulates Heart Failure Devices in Kenya?
The Pharmacy and Poisons Board (PPB) registers medical devices as well as medicines. Source: Pharmacy and Poisons Board. Checked 14 Nov 2026.
How is healthcare paid for in Kenya?
The Social Health Authority (SHA) replaced the National Health Insurance Fund (NHIF) in October 2024. Source: Social Health Authority. Checked 14 Nov 2026.
How many clinical trials on Heart Failure Devices are running in Kenya?
1 study is recruiting, active or about to start in Kenya, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Kenya. Retrieved 12 Nov 2026.
What does WHO report for Kenya?
Early deaths from long-term diseases: 17.1% in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.
How many people in Kenya are 65 or older?
3.0% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 15 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Kenya

See all

Related on cardiovascular

See the topic